000 | 01205 a2200325 4500 | ||
---|---|---|---|
005 | 20250515035029.0 | ||
264 | 0 | _c20060822 | |
008 | 200608s 0 0 eng d | ||
022 | _a0002-9173 | ||
024 | 7 |
_a10.1309/4X8H-VJFK-PHXJ-YMFK _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLum, Gifford | |
245 | 0 | 0 |
_aEvaluation of a protocol to control utilization of B-type natriuretic peptide testing. _h[electronic resource] |
260 |
_bAmerican journal of clinical pathology _cAug 2006 |
||
300 |
_a190-4 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aDelivery of Health Care _xstatistics & numerical data |
650 | 0 | 4 |
_aDiagnostic Tests, Routine _xeconomics |
650 | 0 | 4 | _aHealth Expenditures |
650 | 0 | 4 |
_aHeart Failure _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aUtilization Review |
650 | 0 | 4 | _aVeterans |
773 | 0 |
_tAmerican journal of clinical pathology _gvol. 126 _gno. 2 _gp. 190-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1309/4X8H-VJFK-PHXJ-YMFK _zAvailable from publisher's website |
999 |
_c16479398 _d16479398 |